Small

Zacks Small Cap Research – EZFL: Recent M&A Expected to Enhance Growth Prospects, as Footprint & Fleet Expand – Go Health Pro

by
Zacks Small Cap Research – EZFL: Recent M&A Expected to Enhance Growth Prospects, as Footprint & Fleet Expand – Go Health Pro

By M. Marin NASDAQ:EZFL Advancing strategy to be a leading on-demand mobile fueling company… EzFill Holdings (NASDAQ:EZFL) provides a mobile fuel delivery service that offers convenience to owners of commercial fleets and consumer vehicles. Its target market ranges from individual automobile owners to business fleets. The company brings refueling to the vehicles at their primary … Read more

Zacks Small Cap Research – EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo… – Go Health Pro

by
Zacks Small Cap Research – EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo… – Go Health Pro

By David Bautz, PhD NASDAQ:EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Advancing EB06 for Treating Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease that causes areas of the skin to lose color, … Read more

Zacks Small Cap Research – CBAT: Positive year-end news countered by continued tariff concerns for battery companies. – Go Health Pro

by

By Brian Lantier, CFA NASDAQ:CBAT READ THE FULL CBAT RESEARCH REPORT CBAK (NASDAQ:CBAT) has made a number of announcements recently which may not be fully appreciated by the market and which we believe that the shares currently provide an opportunity for patient investors seeking growth at a reasonable price. • In late December, CBAK noted that … Read more

Zacks Small Cap Research – XFOR: Receives €28.5 Upfront for Licensing Agreement with Norgine… – Go Health Pro

by

By David Bautz, PhD NASDAQ:XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Licensing Agreement with Norgine Includes €28.5 Million Upfront Payment On January 13, 2025, X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) announced an exclusive licensing and supply agreement with Norgine, a European specialty pharmaceutical company that generates greater than €500 million in annual revenues, that covers Europe, … Read more

Zacks Small Cap Research – SDA: SunCar Technology Group’s Growth Potential Supports Price Target of $20.00. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:SDA READ THE FULL SDA RESEARCH REPORT Company Announces New Chief Strategy Officer On January 13, 2025, the SunCar (NASDAQ:SDA) announced that Breaux Walker was appointed Chief Strategy Officer. Mr. Walker will oversee the company’s capital markets strategy, investments, international financing, and investor relations. Mr. Walker has over 25 years of … Read more

x